Prokidney (PROK) Receivables - Accured (2023 - 2026)

Prokidney (PROK) has 4 years of Receivables - Accured data on file, last reported at $1.0 million in Q1 2026.

• Receivables - Accured for Q1 2026 came in at $1.0 million, down 41.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (down 41.1% YoY), and the FY2025 annual result was $1.1 million, down 53.94% from the prior year.
• Receivables - Accured fell to $1.0 million in Q1 2026 per PROK's latest filing, from $1.1 million in the prior quarter.
• Over five years, Receivables - Accured peaked at $8.1 million in Q2 2023 and troughed at $714000.0 in Q3 2023.
• A 4-year average of $2.7 million and a median of $1.8 million in 2025 frame the typical range for Receivables - Accured.
• The sharpest annual moves came in 2024 and 2025: Receivables - Accured jumped 614.57% in 2024, then sank 75.75% in 2025.
• A 4-year view of Receivables - Accured shows it stood at $1.4 million in 2023, then soared by 77.96% to $2.4 million in 2024, then slumped by 53.94% to $1.1 million in 2025, then declined by 8.43% to $1.0 million in 2026.
• Business Quant data shows PROK's Receivables - Accured at $1.0 million in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.